July 6, 2020 / 5:14 AM / a month ago

BRIEF-Idorsia: Positive Results In Second Phase 3 Study Of Daridorexant

July 6 (Reuters) - IDORSIA LTD:

* ANNOUNCES POSITIVE RESULTS IN SECOND PHASE 3 STUDY OF DARIDOREXANT

* RESULTS CONFIRM AND REINFORCE EFFICACY AND SAFETY PROFILE FROM FIRST PIVOTAL STUDY

* COMPANY TARGETS FILING NEW DRUG APPLICATION (NDA) AROUND END OF 2020 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below